Researchers exploit genetic ‘co-dependence’ to kill treatment-resistant tumor cells

Cancer cells fueled by the mutant KRAS oncogene, which makes them notoriously difficult to treat, can be killed by blocking a more vulnerable genetic partner of KRAS, report scientists at the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT. read more

Read the whole article on Harvard Science

More from Harvard Science